NZ312199A - Zwitterionic forms of trovafloxacin - Google Patents

Zwitterionic forms of trovafloxacin

Info

Publication number
NZ312199A
NZ312199A NZ312199A NZ31219996A NZ312199A NZ 312199 A NZ312199 A NZ 312199A NZ 312199 A NZ312199 A NZ 312199A NZ 31219996 A NZ31219996 A NZ 31219996A NZ 312199 A NZ312199 A NZ 312199A
Authority
NZ
New Zealand
Prior art keywords
trovafloxacin
zwitterionic forms
zwitterionic
forms
Prior art date
Application number
NZ312199A
Other languages
English (en)
Inventor
Douglas J M Allen
David B Joseph
Timothy Norris
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NZ312199A publication Critical patent/NZ312199A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Physical Water Treatments (AREA)
  • Processing Of Solid Wastes (AREA)
NZ312199A 1995-08-29 1996-07-29 Zwitterionic forms of trovafloxacin NZ312199A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US297595P 1995-08-29 1995-08-29
PCT/IB1996/000756 WO1997007800A1 (en) 1995-08-29 1996-07-29 Zwitterionic forms of trovafloxacin

Publications (1)

Publication Number Publication Date
NZ312199A true NZ312199A (en) 1999-06-29

Family

ID=21703460

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ312199A NZ312199A (en) 1995-08-29 1996-07-29 Zwitterionic forms of trovafloxacin

Country Status (30)

Country Link
EP (1) EP0850060A1 (pt)
JP (1) JP3188476B2 (pt)
KR (1) KR100343909B1 (pt)
CN (1) CN1190889A (pt)
AP (1) AP636A (pt)
AR (1) AR003985A1 (pt)
AU (1) AU704115B2 (pt)
BR (1) BR9609998A (pt)
CA (1) CA2229786C (pt)
CO (1) CO4480739A1 (pt)
CZ (1) CZ56698A3 (pt)
DZ (1) DZ2087A1 (pt)
GT (1) GT199600072A (pt)
HR (1) HRP960395B1 (pt)
HU (1) HUP9900170A3 (pt)
IL (1) IL122651A (pt)
MA (1) MA23966A1 (pt)
MY (1) MY113874A (pt)
NO (1) NO309814B1 (pt)
NZ (1) NZ312199A (pt)
OA (1) OA10669A (pt)
PE (1) PE12598A1 (pt)
PL (1) PL325170A1 (pt)
RU (1) RU2144921C1 (pt)
SK (1) SK23898A3 (pt)
TN (1) TNSN96109A1 (pt)
TR (1) TR199800339T1 (pt)
WO (1) WO1997007800A1 (pt)
YU (1) YU48396A (pt)
ZA (1) ZA967282B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN1998000106A (es) 1997-08-01 1999-01-08 Pfizer Prod Inc Composiciones parenterales de alatroflaxacino
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US6114531A (en) * 1998-07-28 2000-09-05 Pfizer Inc. Process for preparing quinolone and naphthyridone carboxylic acids
HN1999000141A (es) * 1998-09-03 2000-06-19 Pfizer Prod Inc Procedimiento para preparar sales de trovafloxacina de adicion de acidos.
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164402A (en) * 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids

Also Published As

Publication number Publication date
IL122651A0 (en) 1998-08-16
DZ2087A1 (fr) 2002-07-22
AP636A (en) 1998-04-09
JP3188476B2 (ja) 2001-07-16
SK23898A3 (en) 1999-05-07
KR100343909B1 (ko) 2003-04-10
CA2229786C (en) 2002-02-19
HUP9900170A2 (hu) 1999-05-28
HRP960395A2 (en) 1998-06-30
IL122651A (en) 2000-02-17
RU2144921C1 (ru) 2000-01-27
AU704115B2 (en) 1999-04-15
TR199800339T1 (xx) 1998-06-22
AR003985A1 (es) 1998-09-30
MX9801664A (es) 1998-08-30
HRP960395B1 (en) 2001-12-31
PE12598A1 (es) 1998-03-20
CO4480739A1 (es) 1997-07-09
CZ56698A3 (cs) 1999-02-17
AU6367696A (en) 1997-03-19
TNSN96109A1 (fr) 2005-03-15
GT199600072A (es) 1998-02-14
MA23966A1 (fr) 1997-04-01
BR9609998A (pt) 1999-07-06
OA10669A (en) 2000-11-06
EP0850060A1 (en) 1998-07-01
KR19990044232A (ko) 1999-06-25
AP9600853A0 (en) 1996-10-31
ZA967282B (en) 1998-03-02
NO980862D0 (no) 1998-02-27
YU48396A (sh) 1998-12-23
WO1997007800A1 (en) 1997-03-06
MY113874A (en) 2002-06-29
NO980862L (no) 1998-02-27
NO309814B1 (no) 2001-04-02
JPH10511692A (ja) 1998-11-10
CA2229786A1 (en) 1997-03-06
CN1190889A (zh) 1998-08-19
PL325170A1 (en) 1998-07-06
HUP9900170A3 (en) 1999-11-29

Similar Documents

Publication Publication Date Title
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
PL327569A1 (en) Promedications of thrombosin inhibitors
AU4780596A (en) Hemi-wheeled walker
GB9526560D0 (en) Use of 2-Amino-Heterocycles
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
GB9512290D0 (en) Uses of polyhexanide
IL116924A (en) Preparation of n-aryl - and n-hetarylhydroxylamines
ZA96725B (en) Use of phenyclyclohexylcarboxamides
AP9600853A0 (en) Zwitterionic forms of trovafloxacin
IL113228A0 (en) Derivatives of anandamide
GB9600205D0 (en) Interferometer
IL117786A (en) Preparation of alpha-bisoximes
GB9602060D0 (en) Combined shower
AU6171196A (en) Therapeutic uses of ta99
AU4053295A (en) Shower spa
ZA962440B (en) Destressing of railtracks
SG64924A1 (en) Inhibiting photodecompostion of 3-substituted-2- oxindoles
GB9514072D0 (en) Preparation of thionucleosides
IL115554A0 (en) Earthquake-proofing of structures
CA76199S (en) Set of dishes
HUT75286A (en) New intermediers of ace-inhibitors
HRP950468A2 (en) New medicine - combination of components
PL311976A1 (en) Closed-profile shape of double-o type
GB9503734D0 (en) Manufacture of polyanlines
HU9501741D0 (en) Walker